The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...

With a market cap of $153.4 billion, Amgen Inc. (AMGN) is a global leader in biotechnology, focusing on innovative human ...

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this article, we are going to take a ...

Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a critical juncture in its growth trajectory as it advances its product ...

Today, Benzinga 's options scanner spotted 28 uncommon options trades for Amgen. This isn't normal. The overall sentiment of ...

Storied, a leader in family history and digital storytelling, is thrilled to announce its strategic acquisition of Memory Lane, an artificial intelligence company known for its advanced memory ...

Background: Trifluridine/tipiracil (FTD/TPI) is approved as monotherapy and in combination with bevacizumab for the treatment of patients with refractory metastatic colorectal cancer (mCRC). FTD/TPI ...

IBM stated that this acquisition will enhance its expertise ... IBM)’s dividend history also makes it an appealing investment option. The company has remained committed to its shareholder ...

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

E-commerce major Amazon is all set to acquire fintech company Axio (formerly Capital Float). This will be the second acquisition for the US-based company in the Indian fintech space, following its ...